Flattish growth in FY17; a consolidation year.
Shilpa Medicare - API Capabilities and Capacity. Some data to chew...
Shilpa API v2.pdf (207.5 KB)
Per Mr Bhutada's CNBC Tv18 interview (Making IT Big Season 7, Episode 6)
- Oncology: 44 products are in R&D to come in next 3-4 years
- Non-oncology: 14 products are in R&D to come in next 3-4 years
- Plan to file 8 to 10 ANDAs every year
- Around 32 ANDAs are under pipeline